Clinical Trials Browser

OTHER × Sarcoma × palbociclib × Clear all

Recurrence, Sarcoma, Sarcoma, Ewing

NCT03242382 2024-01-23

PalboSarc

Phase 2 Unknown

40 enrolled

Sarcoma

Chordoma, Sarcoma, Osteosarcoma

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT02897375 2023-10-10

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Phase 1 Completed

71 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT01209598 2017-11-06

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma

Phase 2 Completed

90 enrolled 7 charts

Sarcoma

Liposarcoma, Sarcoma

Clinical Trials

Palbociclib and Pembrolizumab in Sarcoma

Palbociclib + Ganitumab In Ewing Sarcoma

PalboSarc

SMMART Adaptive Clinical Treatment (ACT) Trial

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma